Bart Meulemans

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

Fátima Cardoso, Laura J. van’t Veer, Jan Bogaerts et al. · New England Journal of Medicine · 2016 · 2.1K citations · Full text

Medicine, Genetics, Oncology +16

70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age

Martine Piccart, Laura van ‘t Veer, Coralie Poncet et al. · The Lancet Oncology · 2021 · 358 citations · Full text

Life Sciences, Biostatistics, Oncology +13

Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials

Maja V. Maraldo, Francesco Giusti, Ivan R. Vogelius et al. · The Lancet Haematology · 2015 · 172 citations

Medicine, Cardiology, Oncology +10

Premature Ovarian Failure and Fertility in Long-Term Survivors of Hodgkin's Lymphoma: A European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d'Étude des Lymphomes de l'Adulte Cohort Study

Marleen A. E. van der Kaaij, Natacha Heutte, Paul Meijnders et al. · Journal of Clinical Oncology · 2011 · 132 citations · Full text

Medicine, Gynecology, Oncology +16

Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial 21011 (NCT00

Sean Whittaker, Reinhard Dummer, Annamari Ranki et al. · British Journal of Dermatology · 2012 · 93 citations

Medicine, Dermatology, Oncology +9